Royal London Asset Management
ELV icon

Royal London Asset Management’s Elevance Health ELV Stock Holding History

Royal London Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68.8M Buy
235,180
+1,149
+0.5% +$378K 0.14% 137
2025
Q4 		$82M Sell
234,031
-1,123
-0.5% -$379K 0.17% 120
2025
Q3 		$76M Sell
235,154
-4,232
-2% -$1.32M 0.16% 125
2025
Q2 		$93.1M Sell
239,386
-2,715
-1% -$1.09M 0.21% 92
2025
Q1 		$105M Buy
242,101
+10,792
+5% +$4.33M 0.25% 79
2024
Q4 		$85.3M Buy
231,309
+2,049
+0.9% +$857K 0.21% 86
2024
Q3 		$119M Buy
229,260
+5,960
+3% +$3.18M 0.29% 67
2024
Q2 		$121M Sell
223,300
-23,601
-10% -$12.5M 0.31% 63
2024
Q1 		$128M Buy
246,901
+14,381
+6% +$7.15M 0.32% 64
2023
Q4 		$110M Buy
232,520
+1,962
+0.9% +$907K 0.31% 64
2023
Q3 		$100M Buy
230,558
+9,750
+4% +$4.42M 0.33% 60
2023
Q2 		$98.1M Buy
220,808
+50,402
+30% +$23.3M 0.32% 59
2023
Q1 		$78.3M Buy
170,406
+6,007
+4% +$2.86M 0.31% 63
2022
Q4 		$84.4M Buy
164,399
+1,400
+0.9% +$711K 0.38% 54
2022
Q3 		$74.2M Sell
162,999
-8,576
-5% -$4.1M 0.38% 53
2022
Q2 		$82.8M Sell
171,575
-3,130
-2% -$1.55M 0.38% 56
2022
Q1 		$85.8M Buy
174,705
+17,806
+11% +$8.14M 0.34% 58
2021
Q4 		$72.7M Sell
156,899
-10,901
-6% -$4.59M 0.27% 71
2021
Q3 		$62.5M Buy
167,800
+582
+0.3% +$221K 0.25% 80
2021
Q2 		$63.8M Sell
167,218
-8,895
-5% -$3.4M 0.26% 80
2021
Q1 		$63.2M Buy
176,113
+6,453
+4% +$2.08M 0.29% 74
2020
Q4 		$54.5M Buy
169,660
+2,870
+2% +$881K 0.29% 77
2020
Q3 		$43.3M Sell
166,790
-67,655
-29% -$18.2M 0.26% 82
2020
Q2 		$54.4M Buy
234,445
+85,826
+58% +$22.9M 0.38% 60
2020
Q1 		$34.3M Buy
+148,619
New +$40.5M 0.28% 83
2019
Q4 		– Sell
-147,436
Closed -$35.4M – 646
2019
Q3 		$35.4M Buy
+147,436
New +$40.4M 0.27% 89
2019
Q2 		– Sell
-146,713
Closed -$42.1M – 602
2019
Q1 		$42.1M Buy
146,713
+7,266
+5% +$2.1M 0.33% 73
2018
Q4 		$36.1M Buy
+139,447
New +$38.3M 0.32% 75
2014
Q4 		– Sell
-66,169
Closed -$8.02M – 522
2014
Q3 		$8.02M Buy
66,169
+642
+1% +$73.6K 0.2% 117
2014
Q2 		$7.3M Sell
65,527
-244
-0.4% -$25.1K 0.17% 142
2014
Q1 		$7.04M Sell
65,771
-5,242
-7% -$474K 0.16% 146
2013
Q4 		$6.53M Sell
71,013
-2,856
-4% -$254K 0.17% 142
2013
Q3 		$6.17M Buy
73,869
+567
+0.8% +$48.6K 0.17% 138
2013
Q2 		$5.99M Buy
+73,302
New +$5.49M 0.17% 130

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Royal London Asset Management's ELV Position: Q1 2026 in Review

Royal London Asset Management increased its Elevance Health (ELV) stake by 0.49% in Q1 2026, buying an estimated $378K and bringing the position to 235,180 shares worth $68.8M. The position accounts for 0.14% of the portfolio, ranked #137.

Royal London Asset Management first reported a position in ELV in Q2 2013 and has held it in 34 quarters since. The position peaked at $128M in Q1 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Royal London Asset Management held 235,180 shares of Elevance Health worth $68.8M as of Q1 2026.
  • Royal London Asset Management bought 1,149 Elevance Health shares in Q1 2026, an estimated $378K.
  • Elevance Health made up 0.14% of Royal London Asset Management's portfolio in Q1 2026, its #137 holding.
  • Royal London Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 34 quarters since.
  • Royal London Asset Management's Elevance Health position peaked at $128M in Q1 2024.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Royal London Asset Management's 13F filing for Q1 2026, filed 1 May 2026.